FluiDx-AD Project

Our mission is to develop a novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's disease.

[FluiDx-AD Project @FluiDxAD]

🔬 During #WorldAlzheimersMonth and every day, #Alzheimer’s research moves forward, and the diagnostic journey must also.
❓ How can we make diagnosis more personalised, timely and useful? Learn about the project & saliva- and blood-diagnostic tools here:https://t.co/IW3YiBufWc

[FluiDx-AD Project @FluiDxAD]

This week, #WorldPatientSafetyDay highlighted safer care for all.
🔬 @FluiDxAD is developing a simpler, less invasive way to detect #Alzheimer’s with blood & saliva for earlier diagnosis & more accessible, patient-centred care.
➡️ https://t.co/IW3YiBufWc
@WHO #dementia #research

[FluiDx-AD Project @FluiDxAD]

📢 The second edition of the @FluiDxAD newsletter is out!

Discover our latest project updates, upcoming events and interviews with Marte Sødal and Lukas Gemein.

📖 Read it here: https://t.co/RdlyIOPthL

[FluiDx-AD Project @FluiDxAD]

📢 We’re pleased to share that the second issue of our @FluiDxAD newsletter is coming soon!

👉Missed the first issue? https://t.co/D7564BtkiD

👉Want to receive the second issue directly in your inbox? Register here: https://t.co/kO4Vu1Fzsz

[FluiDx-AD Project @FluiDxAD]

📢 New @FluiDxAD project flyer now available!

The flyer was distributed at the Pre Diagnostics booth during the Healthtech Festival 2026 in Oslo last week. Many thanks to Pre Diagnostics for supporting its visibility 🙏

➡️https://t.co/PqB1A3bD4o

[FluiDx-AD Project @FluiDxAD]

📢The @FluiDxAD General Assembly took place yesterday and brought together partners to review progress, exchange insights and align on the next steps. Having successfully completed our first periodic report, we have now entered Reporting Period 2.

➡️https://t.co/O2KUg75XoR

[FluiDx-AD Project @FluiDxAD]

Project Coordinator Ira Haraldsen makes the care problem clear: long waits can mean missed opportunities.

FluiDx-AD is developing saliva- and blood-based tests intended to make Alzheimer's diagnosis faster and more accessible

For more info, visit https://t.co/bUSuD2iNdQ

[FluiDx-AD Project @FluiDxAD]

“An early diagnosis can help people and families access the right support sooner.”

For #BrainAwarenessWeek, discover how FluiDx-AD is working on saliva- and blood-based biomarker tests for Alzheimer’s disease.

#BAW2026 #BrainAwarenessWeek2026

[FluiDx-AD Project @FluiDxAD]

For #BrainAwarenessWeek, why does early diagnosis matter?
“Being able to obtain an early diagnosis would enable families, and carer members in particular, to plan ahead for lifestyle changes, consider support that will inevitably be needed and hopefully avoid too many crises.”

[FluiDx-AD Project @FluiDxAD]

Our first #FluiDxAD newsletter is out
@FluiDxAD, funded by Horizon Europe, is developing minimally invasive saliva- and blood-based tests to support earlier diagnosis & management of Alzheimer’s disease.
Read: https://t.co/D7564BsMt5
Subscribe: https://t.co/OO4KRnVGql

[FluiDx-AD Project @FluiDxAD]

FluiDx-AD is a Horizon Europe project developing saliva- & blood-based tests for earlier Alzheimer’s disease diagnosis & better access to treatments.
Watch our interview with Vebjørn Andersson from @ResearchNeurOUS:
https://t.co/86scxpzgde
#BrainAwarenessWeek2026 #BAW2026

[FluiDx-AD Project @FluiDxAD]

#BrainAwarenessWeek
By developing innovative saliva- and blood-based diagnostic tests, we strive to improve early detection, facilitate access to next-generation treatments and to enhance the quality of life for millions affected by #Alzheimer’s disease.
https://t.co/1jU9qixeij

[FluiDx-AD Project @FluiDxAD]

Have a read of the latest Alzheimer Europe newsletter, covering how the members of our #H2020 funded @FluiDxAD project's Advisory Board participated in consultation about findings from a systematic review and its communication to the public:
https://t.co/67BsxV7LMt

[FluiDx-AD Project @FluiDxAD]

Members of the @FluiDx_AD Advisory Board participate in consultation about findings from a systematic review about the effects of diagnosing AD via fluid-based biomarker tests.
Many thanks for their valuable feedback and the engaged discussion!
https://t.co/QLUDRNYOCl

[Alzheimer Europe @AlzheimerEurope]

FluiDx-AD holds its first Online Public Advisory Board. @FluiDxAD
https://t.co/MUkua04vdj

[FluiDx-AD Project @FluiDxAD]

Yesterday, project partners @forsyth_faye & @ChrisBintener met with members of @AlzheimerEurope's European Working Group of People with Dementia to discuss how to implement feedback on a saliva sample collection procedure to screen for #Alzheimer’s disease biomarkers.

[Chris Bintener @ChrisBintener]

Today, @forsyth_faye & I met Praveen Sharma to discuss feedback from EWGPWD and EDCWG on a device to detect Alzheimer’s disease biomarkers in saliva.

Next week we’ll focus on how to communicate test results with potential future users. @FluiDxAD
https://t.co/jh5HqxlRvC

[Chris Bintener @ChrisBintener]

Today, @forsyth_faye & I met Praveen Sharma to discuss feedback from EWGPWD and EDCWG on a device to detect Alzheimer’s disease biomarkers in saliva.
Next week we’ll focus on how to communicate test results with potential future users in #H2020 FluiDx-AD: https://t.co/jh5HqxlRvC

[FluiDx-AD Project @FluiDxAD]

Have a read of @alzheimereurope's newsletter, featuring the first #H2020 @FluiDxAD General Assembly & a consultation with the European Working Group of People with Dementia & European Dementia Carers Working Group on a saliva prototype for Alzheimer’s disease biomarkers.

[Alzheimer Europe @AlzheimerEurope]

Check out our October #dementia newsletter, with some spookily good articles to capture your interest this #Halloween!

Highlights include:
News from #35AEC
The latest #DementiainEurope magazine plus its supplement on #BrainHealth
#AEAntiStigmaAward news

https://t.co/9FwENs5GRS

[FluiDx-AD Project @FluiDxAD]

HemoDx, is developing a saliva collection device that could enable cheaper and easier screening for #Alzheimer’s disease.
Together with @alzheimereurope, people affected by dementia provided feedback through structured Public Involvement consultations.

https://t.co/qyx4yTURhC